Genomic Health to present its Oncotype DX multi-gene expression test studies at the 32nd SABCS
August 31, 2015
Location: Exhibit Halls A-B
Sunday, December 13, 2009, 7 a.m. - 8:30 a.m.Abstract: #6004
Poster presentation (Poster Session VI): "HER2 amplification, Polysomy Status and Breast Cancer Survival in a Large Kaiser Permanente Case-Control Study: Assessment of HER2 by Quantitative Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and Fluorescence in Situ Hybridization (FISH)"
Presenter: Rick Baehner, M.D., director of pathology at Genomic Health, Inc., and director of the Immunohistochemistry Core Laboratory at the Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco
Location: Exhibit Halls A-B
Sunday, December 13, 2009, 7 a.m. - 8:30 a.m.Abstract: #6021
Poster presentation (Poster Session VI): "Molecular Characterization of Breast Cancer Core Biopsy Specimens by Gene Expression Analysis Using Standardized Quantitative RT-PCR"
Presenter: Joseph Anderson, M.D., pathologist at Genomic Health, Inc.
Location: Exhibit Halls A-B
SOURCE Genomic Health